Monthly Archives: February 2024

Community Pharmacy England has joined a new coalition of industry and health charities, led by the British In Vitro Diagnostics Association (BIVDA) and former Health Minister Maggie Throup MP, to highlight missed opportunities to tackle Antimicrobial Resistance (AMR). Coming together to set out a call to action for the Government and the NHS, the cross-sector [...]

The post Coalition calls for testing to tackle threat of AMR appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes. MSN/2024/025 Tier 2 – medium impact Date of issue: 27th February 2024 Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes are currently out of stock. Resupply date of this product is to be [...]

The post Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2024. Contractors should note changes made to Part II – Requirements enabling payments to be made for the supply of drugs, appliances and chemical [...]

The post Drug Tariff Watch – March 2024 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date [...]

The post National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.